These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2358848)

  • 21. Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristine.
    Crafts DC; Levin VA; Edwards MS; Pischer TL; Wilson CB
    J Neurosurg; 1978 Oct; 49(4):589-92. PubMed ID: 690688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of supratentorial glioma with intracarotid cisplatin and intravenous carmustine].
    Rebollo J; Martín-Algarra S; Bilbao I; Zubieta JL; Calvo FA; de Castro P; Pastor MA; Viteri C; Martínez Lage JM
    Neurologia; 1990; 5(7):228-32. PubMed ID: 1963067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superselective cerebral arterial infusion of BCNU in high-grade glioma: the radiologist's point of view.
    Fontaine S; Théron J; Melanson D; Villemure JG; Emrich J; Raymond J; Ethier R
    Can Assoc Radiol J; 1988 Sep; 39(3):178-81. PubMed ID: 2971050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central neurotoxicity following intracarotid BCNU chemotherapy for malignant gliomas.
    Mahaley MS; Whaley RA; Blue M; Bertsch L
    J Neurooncol; 1986; 3(4):297-314. PubMed ID: 3958776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined intra-arterial and systemic chemotherapy for recurrent malignant brain tumors.
    Watne K; Hannisdal E; Nome O; Hager B; Hirschberg H
    Neurosurgery; 1992 Feb; 30(2):223-7. PubMed ID: 1312230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of recurrent glioblastoma with intra-arterial BCNU [1, 3-bis (2-chloroethyl)-1-nitrosourea].
    Figueiredo EG; Faria JW; Teixeira MJ
    Arq Neuropsiquiatr; 2010 Oct; 68(5):778-82. PubMed ID: 21049193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intra-arterial and intravenous chemotherapy for the treatment of malignant glioma. Preliminary results.
    Calvo FA; Pastor MA; Dy C; Alegría E; Antón Aparicio LM; Gil A; Harguindey S; Zubieta JL; Martinez Lage M
    Am J Clin Oncol; 1985 Jun; 8(3):200-9. PubMed ID: 4050738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The surgical bed after BCNU polymer wafer placement for recurrent glioma: serial assessment on CT and MR imaging.
    Hammoud DA; Belden CJ; Ho AC; Dal Pan GJ; Herskovits EH; Hilt DC; Brem H; Pomper MG
    AJR Am J Roentgenol; 2003 May; 180(5):1469-75. PubMed ID: 12704070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term survival of patients treated with BCNU for brain tumors.
    Calogero J; Crafts DC; Wilson CB; Boldrey EB; Rosenberg A; Enot KJ
    J Neurosurg; 1975 Aug; 43(2):191-6. PubMed ID: 1185250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)].
    Afra D; Sipos L; Vitanovics D
    Ideggyogy Sz; 2002 Jan; 55(1-2):38-44. PubMed ID: 12122942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomas.
    Miller DF; Bay JW; Lederman RJ; Purvis JD; Rogers LR; Tomsak RL
    Ophthalmology; 1985 Mar; 92(3):402-6. PubMed ID: 2986069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracarotid BCNU for glioma.
    Wolpert SM
    Neurosurgery; 1987 Aug; 21(2):270. PubMed ID: 3658141
    [No Abstract]   [Full Text] [Related]  

  • 33. Single-agent chemotherapy of brain tumors. A five-year review.
    Wilson CB; Gutin P; Boldrey EB; Drafts D; Levin VA; Enot KJ
    Arch Neurol; 1976 Nov; 33(11):739-44. PubMed ID: 185991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to vincristine and Procarbazine of recurrent medulloblastomas. Report of 2 cases.
    Seiler RW; Reichenbach W; Fricker U; Wagner HP
    Helv Paediatr Acta; 1978 Jun; 33(2):177-81. PubMed ID: 659260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating glioma therapies: modeling treatments and predicting outcomes.
    Kirby S; Brothers M; Irish W; Florell R; Macdonald D; Schold C; Cairncross G
    J Natl Cancer Inst; 1995 Dec; 87(24):1884-8. PubMed ID: 7494233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of difluoromethylornithine on the antiglioma therapeutic efficacy of intra-arterial BCNU.
    Cohen AR; Pietronigro DD; Cravioto H; Flamm ES
    J Neurosurg; 1986 Nov; 65(5):671-8. PubMed ID: 3095505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients.
    Jungk C; Chatziaslanidou D; Ahmadi R; Capper D; Bermejo JL; Exner J; von Deimling A; Herold-Mende C; Unterberg A
    BMC Cancer; 2016 Feb; 16():81. PubMed ID: 26865253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and Effectiveness of Bis-Chloroethylnitrosourea Wafer Chemotherapy in Elderly Patients with Recurrent Glioblastoma.
    Klein J; Juratli TA; Radev Y; Daubner D; Soucek S; Schackert G; Krex D
    Oncology; 2017; 93(1):43-50. PubMed ID: 28395288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers.
    Gutenberg A; Bock HC; Brück W; Doerner L; Mehdorn HM; Roggendorf W; Westphal M; Felsberg J; Reifenberger G; Giese A
    Br J Neurosurg; 2013 Dec; 27(6):772-8. PubMed ID: 23662801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial.
    Olivi A; Grossman SA; Tatter S; Barker F; Judy K; Olsen J; Bruce J; Hilt D; Fisher J; Piantadosi S;
    J Clin Oncol; 2003 May; 21(9):1845-9. PubMed ID: 12721262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.